From NBC Bay Area · · 1m 10s
Trump's Drugmaker Investments Spark Democratic Criticism
Democrats report Trump's stock portfolio grew by $56.2m in pharma firms benefiting from Medicare exemptions.
In brief
Democrats report Trump's stock portfolio grew by $56.2m in pharma firms benefiting from Medicare exemptions. Trump's stock holdings in drugmakers that avoid Medicare price negotiations increased to $56.2m by end of 2025, according to Democratic report. Originally reported by NBC Bay Area.
Democrats report Trump's stock growth
Democrats found Trump's pharmaceutical stock holdings grew from $1.7m in 2024 to $56.2m by end of 2025.
Medicare exemption policy details
Republicans' 2025 tax bill expanded exemptions for medications treating rare diseases from medicare price negotiations.
Trump's specific stock purchases
Trump bought up to $950,000 in shares on July 1, 2025, the day the Senate passed the bill.
AbbVie stock acquisition
Trump's portfolio added up to $1 million in AbbVie stock in August 2025 after the bill became law.
Medicare beneficiaries impact
Medicare recipients could pay up to $5,000 more annually for cancer drugs like Keytruda and Opdivo.
White House response
White House spokesperson denied any conflict of interest, saying Trump's portfolio is independently managed.
Recent polling shows public concern
Most Americans believe Trump is profiting from presidency in unethical or illegal ways.
Here's the gist
Trump's stock holdings in drugmakers that avoid Medicare price negotiations increased to $56.2m by end of 2025, according to Democratic report.
